FIBRINOLYTIC ACTIVITY AND CORONARY-ARTERY DISEASE
- 11 May 1968
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 291 (7550), 987-990
- https://doi.org/10.1016/s0140-6736(68)91104-5
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- FIBRINOLYTIC EFFECTS OF DIGUANIDES PLUS ETHYLŒSTRENOL IN OCCLUSIVE VASCULAR DISEASEThe Lancet, 1967
- REDUCTION OF PLATELET STICKINESS BY PHENFORMIN PLUS ETHYLŒSTRENOLThe Lancet, 1967
- Plasma Fibrinogen Patterns in Patients with Coronary AtherosclerosisCirculation, 1966
- FIBRINOLYTIC TREATMENT OF RHEUMATOID ARTHRITIS WITH PHENFORMIN PLUS ETHYLŒSTRENOLThe Lancet, 1966
- FIBRINOLYTIC ACTIVITY RELATED TO AGE IN SURVIVORS OF MYOCARDIAL INFARCTIONThe Lancet, 1966
- PHYSIOLOGY AND PHARMACOLOGY OF FIBRINOLYSISBritish Medical Bulletin, 1964
- Measurement of spontaneous fibrinolytic activityJournal of Clinical Pathology, 1964
- Blood Fibrinolytic Activity in Diabetes Mellitus and Its Bearing on Ischaemic Heart Disease and ObesityBMJ, 1963
- Effect of the ingestion of various fats on the fibrinolytic activity in normal subjects and patients with coronary heart diseaseJournal of Atherosclerosis Research, 1961
- FIBRINOLYSIS, BLOOD CLOTTING, SERUM LIPIDS AND BODY BUILD IN NATIVES OF NEW GUINEA AND AUSTRALIANSInternal Medicine Journal, 1961